Skip to site menu Skip to page content
Logo Image
In Brief
Spotlight

J&J’s Imaavy secures expanded US approval in rare blood disorder

The FDA approval marks another successful step in J&J’s aim of achieving $5bn in peak sales for the drug.

Latest news

Metsera backers establish new biotech armed with China-licensed immunology asset

PHP and ARCH have founded Sentivera, a biotech that now has an immunology licensing deal with China-based Haisco.

ESC 2026: Common pharma excipient linked to uptick in cardiovascular risk

Researchers call for further exploration of xylitol’s impact on heart health as its use in food and pharma continues to rise.

McKesson to acquire Precision Medicine Group for $2.25bn

McKesson believes that the deal will support its clinical research and biopharmaceutical commercialisation services.

Jazz secures FDA approval for Ziihera in advanced HER2+ GEA

The decision follows results from the Phase III HERIZON-GEA-01 trial, which showed significant improvements with Ziihera-based treatments.

BMS Texas investment advances pharma’s modular manufacturing agenda

The company’s flexible production, aided by its multi-modal capabilities, adds to pioneering work by Sanofi, Bayer and Pfizer.